219 related articles for article (PubMed ID: 25339605)
21. VEGF gene promoter polymorphisms and risk of VTE in chemotherapy-treated cancer patients.
Ferroni P; Palmirotta R; Riondino S; De Marchis ML; Nardecchia A; Formica V; Guadagni F; Roselli M
Thromb Haemost; 2016 Jan; 115(1):143-51. PubMed ID: 26336029
[TBL] [Abstract][Full Text] [Related]
22. External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR).
Mahan CE; Liu Y; Turpie AG; Vu JT; Heddle N; Cook RJ; Dairkee U; Spyropoulos AC
Thromb Haemost; 2014 Oct; 112(4):692-9. PubMed ID: 24990708
[TBL] [Abstract][Full Text] [Related]
23. Family history of myocardial infarction and cause-specific risk of myocardial infarction and venous thromboembolism: the Tromsø Study.
Lind C; Enga KF; Mathiesen EB; Njølstad I; Brækkan SK; Hansen JB
Circ Cardiovasc Genet; 2014 Oct; 7(5):684-91. PubMed ID: 25087051
[TBL] [Abstract][Full Text] [Related]
24. Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantation.
Devillier R; Harbi S; Fürst S; Crocchiolo R; El-Cheikh J; Castagna L; Etienne A; Calmels B; Lemarie C; Prebet T; Granata A; Charbonnier A; Rey J; Chabannon C; Faucher C; Vey N; Blaise D
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1560-5. PubMed ID: 24933658
[TBL] [Abstract][Full Text] [Related]
25. Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia.
Chen YB; Coughlin E; Kennedy KF; Alyea EP; Armand P; Attar EC; Ballen KK; Cutler C; Dey BR; Koreth J; McAfee SL; Spitzer TR; Antin JH; Soiffer RJ; Ho VT
Biol Blood Marrow Transplant; 2013 Jun; 19(6):981-7. PubMed ID: 23562738
[TBL] [Abstract][Full Text] [Related]
26. Inherited risk factors in low-risk venous thromboembolism in patients under 45 years.
Yilmaz S; Gunaydin S
Interact Cardiovasc Thorac Surg; 2015 Jan; 20(1):21-3. PubMed ID: 25326427
[TBL] [Abstract][Full Text] [Related]
27. Incidence and predictors of venous thromboembolism in post-acute care patients. A prospective cohort study.
Scannapieco G; Ageno W; Airoldi A; Bonizzoni E; Campanini M; Gussoni G; Silingardi M; Valerio A; Zilli C; Iori I;
Thromb Haemost; 2010 Oct; 104(4):734-40. PubMed ID: 20664897
[TBL] [Abstract][Full Text] [Related]
28. The role of fibrinogen plasma levels, the -455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis.
Tiedje V; Dunkler D; Ay C; Horvath B; Quehenberger P; Pabinger M; Zielinski C; Pabinger I; Mannhalter C
Thromb Haemost; 2011 Nov; 106(5):908-13. PubMed ID: 21901234
[TBL] [Abstract][Full Text] [Related]
29. Novel high-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in intermediate risk lung cancer patients.
Ferroni P; Martini F; Portarena I; Massimiani G; Riondino S; La Farina F; Mariotti S; Guadagni F; Roselli M
Clin Lung Cancer; 2012 Nov; 13(6):482-7. PubMed ID: 22591606
[TBL] [Abstract][Full Text] [Related]
30. Venous thromboembolism in patients with chronic lymphocytic leukemia.
Šimkovič M; Vodárek P; Motyčková M; Belada D; Vrbacký F; Žák P; Smolej L
Thromb Res; 2015 Dec; 136(6):1082-6. PubMed ID: 26467608
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and clinical significance of incidental and clinically suspected venous thromboembolism in lung cancer patients.
Connolly GC; Menapace L; Safadjou S; Francis CW; Khorana AA
Clin Lung Cancer; 2013 Nov; 14(6):713-8. PubMed ID: 23891560
[TBL] [Abstract][Full Text] [Related]
32. Incidence, risk factors and clinical features of venous thromboembolism in newly diagnosed lymphoma patients: results from a prospective cohort study with Asian population.
Park LC; Woo SY; Kim S; Jeon H; Ko YH; Kim SJ; Kim WS
Thromb Res; 2012 Sep; 130(3):e6-12. PubMed ID: 22507288
[TBL] [Abstract][Full Text] [Related]
33. Hyperferritinemia at diagnosis predicts relapse and overall survival in younger AML patients with intermediate-risk cytogenetics.
Lebon D; Vergez F; Bertoli S; Harrivel V; De Botton S; Micol JB; Marolleau JP; Récher C
Leuk Res; 2015 Aug; 39(8):818-21. PubMed ID: 26002512
[TBL] [Abstract][Full Text] [Related]
34. Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism.
White RH; Chan WS; Zhou H; Ginsberg JS
Thromb Haemost; 2008 Aug; 100(2):246-52. PubMed ID: 18690344
[TBL] [Abstract][Full Text] [Related]
35. Venous thromboembolism in uterine cancer.
Rodriguez AO; Gonik AM; Zhou H; Leiserowitz GS; White RH
Int J Gynecol Cancer; 2011 Jul; 21(5):870-6. PubMed ID: 21666485
[TBL] [Abstract][Full Text] [Related]
36. Characteristics of acute myeloid leukemia with myelodysplasia-related changes: A retrospective analysis in a cohort of Chinese patients.
Xu XQ; Wang JM; Gao L; Qiu HY; Chen L; Jia L; Hu XX; Yang JM; Ni X; Chen J; Lü SQ; Zhang WP; Song XM
Am J Hematol; 2014 Sep; 89(9):874-81. PubMed ID: 24861848
[TBL] [Abstract][Full Text] [Related]
37. Venous thromboembolism and nonsmall cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group trials.
Hicks LK; Cheung MC; Ding K; Hasan B; Seymour L; Le Maître A; Leighl NB; Shepherd FA
Cancer; 2009 Dec; 115(23):5516-25. PubMed ID: 19711465
[TBL] [Abstract][Full Text] [Related]
38. Acute myeloid leukaemia in Western Australia 1991-2005: a retrospective population-based study of 898 patients regarding epidemiology, cytogenetics, treatment and outcome.
Gangatharan SA; Grove CS; P'ng S; O'Reilly J; Joske D; Leahy MF; Threlfall T; Wright MP
Intern Med J; 2013 Aug; 43(8):903-11. PubMed ID: 23611681
[TBL] [Abstract][Full Text] [Related]
39. Hypercoagulability and other risk factors in trauma intensive care unit patients with venous thromboembolism.
Van Haren RM; Valle EJ; Thorson CM; Jouria JM; Busko AM; Guarch GA; Namias N; Livingstone AS; Proctor KG
J Trauma Acute Care Surg; 2014 Feb; 76(2):443-9. PubMed ID: 24398771
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological analysis of near-tetraploidy/tetraploidy acute myeloid leukaemia.
Pang CS; Pettenati MJ; Pardee TS
J Clin Pathol; 2015 Mar; 68(3):236-40. PubMed ID: 25563333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
